Introducción: En la actualidad los sistemas de salud alrededor del mundo apuestan por una toma decisiones clínicas basadas en la evidencia científica. Para ello, es necesario que los profesionales de la salud consulten los resultados de las investigaciones científicas. Sin embargo, dada la gran cantidad de literatura, los investigadores han desarrollado metodologías de revisión para compilar los estudios científicos dentro de un área específica. Aun cuando existen más de 10 tipos de metodologías para la revisión de la literatura, la Revisión Sistemática Exploratoria (RSE) ha recibido poca atención en la literatura sobre métodos de investigación científica de habla hispana. Objetivo: Detallar la metodología de la RSE, sus propósitos y las fases para su desarrollo. Desarrollo: Este trabajo detalla las generalidades de la RSE basándose en la metodología propuesta por Arksey & O’Malley. Así mismo, se describen las áreas o ámbitos donde este tipo de revisión se puede emplear, las fases para desarrollar la revisión y ejemplos de las RSE. Conclusiones: Las RSE tienen la fortaleza de hacer saber a los profesionales de la salud sobre un tema en específico que permita incidir en las políticas públicas. Al igual que las Revisiones Sistemáticas, las RSE utilizan una metodología clara y replicable, aportando datos confiables y científicos para los profesionales de la salud.

Setting: In January 2021, the COVID-19 vaccine became available to First Nations, Métis, and Inuit (FNMI) over the age of 65 living in First Nations communities or Métis settlements in Alberta. In March, vaccine eligibility in Alberta expanded to include FNMI peoples of younger ages and in urban settings. The Métis Nation of Alberta (MNA) and other Indigenous organizations recognized that FNMI populations might be better served by tailored vaccine programs.Intervention: The MNA is the government for the Métis people in Alberta. During the COVID-19 pandemic, the MNA has supported its citizens, through financial and mental wellness support, access to personal protective equipment, and messaging regarding public health orders. When vaccines became available, culturally appropriate virtual vaccine information sessions were provided. In March 2021, the MNA delivered the first Métis-led COVID-19 vaccination clinic. Unique to the clinic’s success was the location, online booking process, and community presence. The clinic focused on cultural safety, including the availability of Indigenous health professionals to community members, and cultural reference points throughout the clinic.Outcomes: In the first MNA clinic, over 1300 people were vaccinated. Visitors shared appreciation for the culturally specific aspects of the clinic, which contributed to increased safety and comfort.Implications: Based on the success of the first Métis-led vaccination clinic, similar services in communities with high numbers of Métis people have been approved. This innovative practice initiative could provide a model of COVID-19 vaccine service delivery that could be used to meet the needs of Métis citizens in other jurisdictions in Canada.

The burden of the current COVID-19 pandemic is not shared equally in Canadian society, with Indigenous Peoples being disproportionately affected. Moreover, there is a lack of research pertaining to vaccination behaviour in Métis communities. This Métis-specific and Métis-led qualitative study endeavours to understand COVID-19 vaccine behaviour among citizens of the Métis Nation of Ontario (MNO). Data was collected via one-on-one interviews. Participants were recruited via the MNO's existing social media channels. Participants filled out a screening survey indicating their intention to vaccinate against COVID-19 as yes, no, or unsure. Sixteen participants (9 yes, 3 unsure, 4 no) were interviewed. Interviews averaged 30 min, and the questions and probes were developed in collaboration with the MNO. The interviewer received Métis-specific cultural safety training. Interviews were transcribed verbatim and uploaded to NVivo 12. A deductive analysis using the Social Ecological Model framework (SEM) for vaccine behaviour and two blinded coders was used to understand the data. An additional factor, COVID-19 public health measures, was added to the framework to better capture the experiences of participants during the COVID-19 pandemic. Overall, the factors with the greatest number of coded references included Vaccine roll-out and availability, Organization of the public into priority groups, Public discourse, Interpersonal influences, Interface with health professionals, Knowledge state, Trust, and Vaccine risk perception. Bandwagoning (following others' behaviour) and Freeloading (perceiving enough people have been vaccinated), both factors of the SEM, were not discussed. Yes, no, and unsure participant groups were compared to understand the influences of each factor based on COVID-19 vaccination intention. MNO citizens COVID-19 vaccine behaviour was negatively and positively influenced by a number of factors. This information will allow the MNO and public health units to better tailor their messaging for COVID-19 vaccine uptake campaigns and future pandemic emergencies.

Introduction Fragmentation in immunisation reporting systems pose challenges in measuring vaccine coverage for First Nations children in Canada. Some Nations have entered into data-sharing agreements with the province of Alberta’s health ministry, enabling novel opportunities to calculate coverage. Methods Partnering with a First Nations community in Alberta, this retrospective cohort study calculated routine childhood vaccine coverage. Administrative data for vaccines delivered within and outside the community were linked to calculate partial and complete immunisation coverage in 2013–2019 at ages 2 and 7 years for children living in the community. We also compared vaccine coverage each year for (a) children who were and were not continuous community residents and (b) children who received or not their first vaccine at the on-reserve community health centre. We also calculated the mean complete coverage across all study years with 95% CIs. Results For most vaccines, coverage was higher (p<0.05) at ages 2 and 7 years for children that received their first vaccine at the First Nations health centre, compared with those who received their first dose elsewhere. For example, for pneumococcal vaccine, the mean level of complete coverage in 2-year-olds was 55.7% (52.5%–58.8%) for those who received their first vaccine in the community, compared with 33.3% (29.4%–37.3%) for those who did not; it was also higher at 7 years (75.6%, 72.7%–78.5%, compared with 55.5%, 49.7%–61.3%). Conclusion Initiating the vaccine series at the on-reserve community health centre had a positive impact on coverage. The ability to measure accurate coverage through data-sharing agreements and vaccine record linkage will support First Nations communities in identifying individual and community immunity. The findings also support the transfer of health funding and service delivery to First Nations to improve childhood immunisation uptake.

Introducción: La Exploración Ambiental es una metodología integrada por un conjunto de estrategias que envuelven un proceso organizado y sistemático para buscar, recopilar, analizar, y estructurar información sobre un tema en específico. Los objetivos de la Exploración Ambiental se centran en la exploración de procesos, ventajas y desventajas, así como la aportación de elementos fundamentales para la toma de decisiones. Objetivo: Describir un marco metodológico para realizar Exploraciones Ambientales de materiales, recursos, y herramientas en ciencias de la salud. Desarrollo: Este trabajo detalla las siete fases propuestas para elaborar las Exploraciones Ambientales en el área de ciencias de la salud. Las fases incluyen Conclusiones: Este artículo hace una propuesta de metodología con etapas definidas que pueden servir como referente para llevar a cabo Exploraciones Ambientales con una estandarización de las etapas a seguir, indispensables para los investigadores sanitarios.

Aim: The purpose of this study is to describe the scope, breadth, and depth of the existing literature on the acceptability of, access to, and uptake of HPV vaccine in mental health populations. Subject and methods: Human papillomavirus (HPV) is responsible for significant cancer morbidity and mortality. Effective vaccines are available; however, uptake is suboptimal. Mental disorders are common, and people with mental disorders are known to have lower rates of cancer screening and reduced uptake of preventive health measures than the general population. This scoping review involved a comprehensive search of published literature. Two independent reviewers screened articles in duplicate and extracted data. Data were analyzed and mapped using quantification of study characteristics. Results: There were 16 quantitative studies included, all conducted in high-resource countries. Studies were focused on youth and adolescents (n = 8), youth and adults (n = 3), or adults (n = 5); and explored substance use disorder (n = 9), mental disorders such as anxiety, depression or others (n = 6), or developmental/intellectual disabilities (n = 4). One study looked at gender identity disorder. There were studies about access to (n = 4), acceptability of (n = 4), and uptake of (n = 13) HPV vaccination. No studies described a theoretical approach to their work. Conclusion: There is limited research available on the relationship between mental health and HPV vaccination acceptability, access, or uptake. Efforts should be made to extend both quantitative and qualitative literature in this area, including using theoretical frameworks to improve the transferability of research into practice.